Results 201 to 210 of about 212,880 (258)

Continuation, Resumption, and Withdrawal Rates of CGRP-mAb Treatment for Migraine Under Real-World Clinical Conditions in Which Patients Are Free to Choose Own Treatment. [PDF]

Neurol Int
Tanei T, Yamashita S, Maesawa S, Nishimura Y, Ishizaki T, Nagashima Y, Suzuki T, Hamasaki H, Yamamoto S, Wakabayashi T, Saito R.   +10 more
europepmc   +1 more source

The Temporal Associations of Neck Pain and Headache - Implications for the Diagnostic Approach to the Myofascial Involvement in Migraine. [PDF]

J Cent Nerv Syst Dis
Börner-Schröder C, Lachhammer T, Behrendt P, Pfeifer T, Kolorz P, Lense S, Pompignoli J, Reichert M, Schramm S, Heinen F, Sollmann N, Bonfert MV.   +11 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Migraine

Nature Reviews Disease Primers, 2022
Migraine is a common, chronic, disorder that is typically characterized by recurrent disabling attacks of headache and accompanying symptoms, including aura. The aetiology is multifactorial with rare monogenic variants. Depression, epilepsy, stroke and myocardial infarction are comorbid diseases.
Michel D Ferrari, Peter Goadsby, Rami Burstein   +2 more
exaly   +6 more sources

Global epidemiology of migraine and its implications for public health and health policy

Nature Reviews Neurology, 2023
Timothy J Steiner, Lars Jacob Stovner
exaly   +2 more sources

Migraine: epidemiology and systems of care

Lancet, The, 2021
Messoud Ashina, Thien Phu Do, Dawn C Buse   +2 more
exaly   +2 more sources

CGRP as the target of new migraine therapies — successful translation from bench to clinic

Nature Reviews Neurology, 2018
Lars Edvinsson, Kristian A Haanes, Karin Warfvinge   +2 more
exaly   +2 more sources

Migraine

Annals of Internal Medicine, 2023
Migraine affects about 1 billion people worldwide, and up to 15% of adults in the United States have migraine attacks in any given year. Migraine is associated with substantial adverse socioeconomic and personal effects. It is the second leading cause of years lived with disability worldwide for all ages and the leading cause in women aged 15 to 49 ...
Niushen Zhang, Matthew S. Robbins
openaire   +2 more sources

Global, regional, and national burden of migraine in 204 countries and territories, 1990 to 2019.

Pain, 2021
Data from the Global Burden of Disease Study 2019 were used to report the burden of migraine in 204 countries and territories during the period 1990 to 2019, through a systematic analysis of point prevalence, annual incidence, and years lived with ...
S. Safiri, H. Pourfathi, Arielle Eagan, M. Mansournia, M. Khodayari, M. Sullman, J. Kaufman, G. Collins, Haijiang Dai, Nicola Luigi Bragazzi, Ali-Asghar Kolahi   +10 more
semanticscholar   +1 more source